arrow_left You’re on the news side, go back to data on Novo

News on Novo

31 days ago

There has been 10 news on Novo in the past from 6 different sources and amongst 2 sections:

Latest news

The Wall Street Journal link
31 days ago
Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready To Meet Demand?
The Hill link
86 days ago
Novo CEO to blame drug middlemen
Bloomberg link
90 days ago
Novo's Wegovy Puts a Higher Price on Heart Health in the US
Bloomberg link
133 days ago
Lilly Gains in Obesity Race With Novo as Supplies Expand
CNBC News link
143 days ago
Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says
Bloomberg link
231 days ago
Novo Won't Meet Wegovy Demand in Short-Medium Term: CFO
Axios link
318 days ago
Wegovy maker Novo inks $16.5 billion acquisition of Catalent to boost supply
The Wall Street Journal link
323 days ago
Why Obesity Drug Coverage Doesn't Matter (Yet) for Lilly and Novo
CNBC News link
404 days ago
Lilly trades at a premium to Ozempic maker Novo as obesity drugs boom. Here's why, analyst says
Reuters link
481 days ago
Catalent's Indiana plant to make Novo's Wegovy weight-loss drug
Going further
dataset_white Full dataset

Evolution through time

Distribution by publisher

There has been 6 publishers reporting on this, including: Bloomberg (30%), CNBC News (20%), The Wall Street Journal (20%), The Hill (10%), Reuters (10%) .

Details

This content can be used under the CC BY 4.0 license